Stay updated on NYX-2925 Efficacy & Safety in Fibromyalgia: Clinical Trial
Sign up to get notified when there's something new on the NYX-2925 Efficacy & Safety in Fibromyalgia: Clinical Trial page.

Latest updates to the NYX-2925 Efficacy & Safety in Fibromyalgia: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision history shows an addition of v3.3.4 and a deletion of v3.3.3 in the study record history, which are administrative updates to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedFooter policy reference updated: the HHS Vulnerability Disclosure link was removed and the page now shows Revision: v3.3.3. This change does not affect study data or core navigation beyond policy references.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedRemoval of the government funding and operating-status banner from the page; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedThe Record History page shows a visual redesign; the version history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check102 days agoChange DetectedMajor update to core content: new government funding/operating status notice and version bump to v3.2.0, replacing v3.1.0.SummaryDifference10%

Stay in the know with updates to NYX-2925 Efficacy & Safety in Fibromyalgia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NYX-2925 Efficacy & Safety in Fibromyalgia: Clinical Trial page.